期刊文献+

复方阿嗪米特治疗老年患者消化不良的疗效观察 被引量:2

The Effect of Compound Azintamide on Dyspepsia Symptoms in the Elderly
下载PDF
导出
摘要 目的:观察复方阿嗪米特肠溶片治疗老年患者消化不良的疗效和安全性。方法:将消化内科门诊130例年龄≥60岁的消化不良患者,随机分为治疗组(A组)、对照组(B组),分别为70例和60例,治疗组给予复方阿嗪米特肠溶片治疗(2片/次,3次/d)2周,观察治疗前后上腹胀、上腹部不适、食欲不振的症状积分变化,计算有效率,同时观察记录不良事件。结果:与对照组相比,治疗组治疗2周后各消化不良症状积分均小于对照组,症状积分改善率均显著高于对照组(P<0.01),无严重不良反应发生。结论:复方阿嗪米特肠溶片可显著改善老年人的消化不良症状,且具有良好的安全性。 Objective:To investigate the efficacy and safety of compound azintamide on dyspepsia symptoms in the elderly.Methods: 130 patients(age≥60)with dyspepsia were divided into two groups randomly.The treatment group(n=70) received compound azintamide.Two tablets of compound azintamide were administered orally following a meal,tid for 2 weeks. The changes of symptoms score of abdominal distention, abdominal discomfort, poor appetite and effective rate as well as adverse events were recorded.Results:Symptom scores were significantly decreased after 2 weeks of compound azintamide(P〈0.01).The effective rate of symptoms was more significant in the treatment group.There were no side effects in any of the patients during the treatment.Conclusion:Compound azintamide showed effective and safety in treatment of elderly patients with dyspepsia symptoms.
作者 赵莉 许乐
出处 《中国医药导刊》 2010年第4期619-620,共2页 Chinese Journal of Medicinal Guide
关键词 消化不良 老年 复方阿嗪米特 Dyspepsia Elderly Compound azintamide
  • 相关文献

参考文献6

二级参考文献22

  • 1上海市泌特临床协作组.复方阿嗪米特肠溶片治疗消化不良的多中心、随机、双盲、安慰剂平行对照临床研究[J].胃肠病学,2005,10(2):83-87. 被引量:91
  • 2邹多武,许国铭,苏暾,陆建萍.复方阿嗪米特治疗功能性消化不良、慢性胆囊炎、胆结石、肝硬化腹胀的疗效观察[J].中华消化杂志,2005,25(7):421-424. 被引量:97
  • 3孙泓,蒲小平.阿嗪米特对豚鼠胆囊胆固醇结石的治疗作用[J].中国新药杂志,2006,15(24):2123-2126. 被引量:29
  • 4Holtmann G, Gschossmann J, Mayr P, et al. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther, 2002, 16: 1641-1648.
  • 5Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology, 2002, 122: 1521-1525.
  • 6Suarez F, Levitt MD, Adshead J, et al. Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. Dig Dis Sci, 1999, 44: 1317-1321.
  • 7Andersen BN, Scheel J, Rune SJ, Worning H. Exocrine pancreatic function in patients with dyspepsia. Hepatogastroenterology, 1982, 29: 35~37.
  • 8Alvisi V, Bettini L, Blasi A, D'Arienzo A, D'Ambrosi A,Di Simone A, Mangiameli A, Muiesan G, Esposito P,Sollazzo R. Analysis of the symptomatologic components of dyspepsia and their response to treatment with different preparations of ursodeoxycholic acid. Controlled multicenter study. Clin Ter, 1983, 107: 291~295.
  • 9HoltmannG, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther, 2002, 16:1641 ~1648.
  • 10Salvioli G, Carati L, Lugli R. Steatorrhoea in cirrhosis:effect of ursodeoxycholic acid administration. J Int Med Res, 1990, 18: 289~297.

共引文献133

同被引文献32

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部